A pharmacokinetic study comparing the biosimilar HEC14028 and Dulaglutide (Trulicity®) in healthy Chinese subjects

• Egile Nagusiak: Xianglei Gao (Egilea), Yujing Di (Egilea), Yuan Lv (Egilea), Yingcai Luan (Egilea), Yang Xiong (Egilea), Yuli Xu (Egilea), Yusheng Li (Egilea), Linfeng Guo (Egilea), Xiaoping Li (Egilea), Li Deng (Egilea), Yulei Zhuang (Egilea), Jie Hou (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2024-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract This study aimed to evaluate the pharmacokinetics (PKs), safety, and immunogenicity of the biosimilar HEC14028 compared to reference Trulicity® (dulaglutide) in healthy male Chinese subjects. This study was a single‐center, randomized, open, single‐dose, parallel‐controlled comparative Phas...